GB0516661D0 - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number
GB0516661D0
GB0516661D0 GBGB0516661.6A GB0516661A GB0516661D0 GB 0516661 D0 GB0516661 D0 GB 0516661D0 GB 0516661 A GB0516661 A GB 0516661A GB 0516661 D0 GB0516661 D0 GB 0516661D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic agents
therapeutic
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0516661.6A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to GBGB0516661.6A priority Critical patent/GB0516661D0/en
Publication of GB0516661D0 publication Critical patent/GB0516661D0/en
Priority to TW095128062A priority patent/TW200728300A/zh
Priority to ARP060103449A priority patent/AR055368A1/es
Priority to CNA2006800374501A priority patent/CN101282963A/zh
Priority to EP06779114A priority patent/EP1915364A1/en
Priority to CA002619228A priority patent/CA2619228A1/en
Priority to AU2006281300A priority patent/AU2006281300A1/en
Priority to RU2008108179/04A priority patent/RU2008108179A/ru
Priority to MX2008002065A priority patent/MX2008002065A/es
Priority to KR1020087004570A priority patent/KR20080039939A/ko
Priority to BRPI0614626-0A priority patent/BRPI0614626A2/pt
Priority to PCT/GB2006/002990 priority patent/WO2007020388A1/en
Priority to JP2008526536A priority patent/JP2009504717A/ja
Priority to UY29741A priority patent/UY29741A1/es
Priority to IL188759A priority patent/IL188759A0/en
Priority to NO20080372A priority patent/NO20080372L/no
Priority to ZA200800698A priority patent/ZA200800698B/xx
Priority to EC2008008250A priority patent/ECSP088250A/es
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GBGB0516661.6A 2005-08-13 2005-08-13 Therapeutic agents Ceased GB0516661D0 (en)

Priority Applications (18)

Application Number Priority Date Filing Date Title
GBGB0516661.6A GB0516661D0 (en) 2005-08-13 2005-08-13 Therapeutic agents
TW095128062A TW200728300A (en) 2005-08-13 2006-08-01 Therapeutic agents
ARP060103449A AR055368A1 (es) 2005-08-13 2006-08-08 Derivados de pirazol, composiciones farmaceuticas que los contienen y su uso en la preparacion de medicamentos para el tratamiento de enfermedades neurodegenerativas y la obesidad
JP2008526536A JP2009504717A (ja) 2005-08-13 2006-08-09 治療薬としてのピラゾール誘導体
MX2008002065A MX2008002065A (es) 2005-08-13 2006-08-09 Derivados de pirazola como agentes terapeuticos.
BRPI0614626-0A BRPI0614626A2 (pt) 2005-08-13 2006-08-09 composto, formulação farmacêutica, uso de um composto, e, método para tratar doenças
CA002619228A CA2619228A1 (en) 2005-08-13 2006-08-09 Pyrazole derivatives as therapeutic agents
AU2006281300A AU2006281300A1 (en) 2005-08-13 2006-08-09 Pyrazole derivatives as therapeutic agents
RU2008108179/04A RU2008108179A (ru) 2005-08-13 2006-08-09 Производные пиразола в качестве терапевтических агентов
CNA2006800374501A CN101282963A (zh) 2005-08-13 2006-08-09 用作治疗药的吡唑衍生物
KR1020087004570A KR20080039939A (ko) 2005-08-13 2006-08-09 치료제로서의 피라졸 유도체
EP06779114A EP1915364A1 (en) 2005-08-13 2006-08-09 Pyrazole derivatives as therapeutic agents
PCT/GB2006/002990 WO2007020388A1 (en) 2005-08-13 2006-08-09 Pyrazole derivatives as therapeutic agents
UY29741A UY29741A1 (es) 2005-08-13 2006-08-11 Sales de 1,5- diaril pirazol-3-carboxamidas, procesos de preparación, composeciones farmacéuticas que las contienen, aplicaciones y métodos de uso.
IL188759A IL188759A0 (en) 2005-08-13 2008-01-14 Pyrazole derivatives as therapeutic agents
NO20080372A NO20080372L (no) 2005-08-13 2008-01-21 Pyrazolderivater som teraputiske midler
ZA200800698A ZA200800698B (en) 2005-08-13 2008-01-23 Pyrazole derivatives as therapeutic agents
EC2008008250A ECSP088250A (es) 2005-08-13 2008-03-07 Derivados de pirazol como agentes terapéuticos

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0516661.6A GB0516661D0 (en) 2005-08-13 2005-08-13 Therapeutic agents

Publications (1)

Publication Number Publication Date
GB0516661D0 true GB0516661D0 (en) 2005-09-21

Family

ID=35098275

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0516661.6A Ceased GB0516661D0 (en) 2005-08-13 2005-08-13 Therapeutic agents

Country Status (18)

Country Link
EP (1) EP1915364A1 (xx)
JP (1) JP2009504717A (xx)
KR (1) KR20080039939A (xx)
CN (1) CN101282963A (xx)
AR (1) AR055368A1 (xx)
AU (1) AU2006281300A1 (xx)
BR (1) BRPI0614626A2 (xx)
CA (1) CA2619228A1 (xx)
EC (1) ECSP088250A (xx)
GB (1) GB0516661D0 (xx)
IL (1) IL188759A0 (xx)
MX (1) MX2008002065A (xx)
NO (1) NO20080372L (xx)
RU (1) RU2008108179A (xx)
TW (1) TW200728300A (xx)
UY (1) UY29741A1 (xx)
WO (1) WO2007020388A1 (xx)
ZA (1) ZA200800698B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008015033A1 (de) 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituierte (Pyrazolyl-carbonyl)imidazolidinone und ihre Verwendung
DE102008015032A1 (de) 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituierte Pyrazolamide und ihre Verwendung
DE102008062878A1 (de) 2008-12-17 2010-06-24 Aicuris Gmbh & Co. Kg Substituierte Furancarboxamide und ihre Verwendung
DE102008062863A1 (de) 2008-12-17 2010-06-24 Aicuris Gmbh & Co. Kg Substituierte (Thiophenyl-carbonyl)imidazolidinone und ihre Verwendung
DE102009036604A1 (de) 2009-07-30 2011-02-03 Aicuris Gmbh & Co. Kg Substituierte Bis-Arylpyrazolamide mit terminaler primärer Amidfunktionalisierung und ihre Verwendung
DE102011055815A1 (de) 2011-11-29 2013-05-29 Aicuris Gmbh & Co. Kg Carboxamid-substituierte Heteroaryl-Pyrazole und ihre Verwendung
DE102012016908A1 (de) 2012-08-17 2014-02-20 Aicuris Gmbh & Co. Kg Tris-(Hetero)Aryl-Pyrazole und ihre Verwendung
CN105061227A (zh) * 2015-07-27 2015-11-18 广东先强药业有限公司 一种环保的盐酸利托君生产方法
WO2020123855A1 (en) 2018-12-12 2020-06-18 University Of Washington Inhibitor compounds for male contraception

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2379076T3 (es) * 2002-12-02 2012-04-20 Astellas Pharma Inc. Derivados de pirazol útiles como inhibidores de COX-I
US7247628B2 (en) * 2002-12-12 2007-07-24 Pfizer, Inc. Cannabinoid receptor ligands and uses thereof
DE602005016082D1 (de) * 2004-02-20 2009-10-01 Astrazeneca Ab 3-substituierte 1,5-diphenylpyrazolderivate, die sich als cb1-modulatoren eignen

Also Published As

Publication number Publication date
IL188759A0 (en) 2008-08-07
NO20080372L (no) 2008-04-16
BRPI0614626A2 (pt) 2012-12-04
WO2007020388A1 (en) 2007-02-22
CA2619228A1 (en) 2007-02-22
ZA200800698B (en) 2009-01-28
AU2006281300A1 (en) 2007-02-22
RU2008108179A (ru) 2009-09-20
MX2008002065A (es) 2008-04-16
ECSP088250A (es) 2008-04-28
KR20080039939A (ko) 2008-05-07
UY29741A1 (es) 2007-03-30
CN101282963A (zh) 2008-10-08
AR055368A1 (es) 2007-08-22
JP2009504717A (ja) 2009-02-05
EP1915364A1 (en) 2008-04-30
TW200728300A (en) 2007-08-01

Similar Documents

Publication Publication Date Title
EP1962961A4 (en) HALF-BODY: THERAPEUTIC AGENTS ACTIVATED BY DIMÉRIZATION
GB0506147D0 (en) Therapeutic agents
EP1730148A4 (en) USE OF AMINOBENZOXAZOLES AS THERAPEUTIC AGENTS
GB0519797D0 (en) Therapeutic agents
GB0521139D0 (en) Therapeutic agent
GB0505437D0 (en) Therapeutic agents
GB0505725D0 (en) Therapeutic agents
GB0615545D0 (en) Therapeutic agent
GB0518819D0 (en) Therapeutic agents
GB0519350D0 (en) Therapeutic agents
GB0518817D0 (en) Therapeutic agents
GB0516661D0 (en) Therapeutic agents
GB0514738D0 (en) Therapeutic agents
GB0507003D0 (en) Therapeutic
GB0518720D0 (en) Therapeutic combination
GB0501655D0 (en) Therapeutic use
GB0523998D0 (en) Therapeutic agents
GB0508153D0 (en) Therapeutic agent
GB0400193D0 (en) Therapeutic agents
GB0522433D0 (en) Therapeutic agents
GB0400196D0 (en) Therapeutic agents
GB0402918D0 (en) Therapeutic agents
GB0403779D0 (en) Therapeutic agents
GB0516496D0 (en) Therapeutic agents
GB0513208D0 (en) Therapeutic agents

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)